Loading organizations...
Loading organizations...
Drug development company focused on neurotransmitter-related diseases.
CeNeRx BioPharma has raised $32.9M across 3 funding rounds.
CeNeRx BioPharma has raised $32.9M in total across 3 funding rounds.
CeNeRx BioPharma has raised $32.9M in total across 3 funding rounds.
CeNeRx BioPharma's investors include L Capital Partners, Omega Funds, Pappas Ventures, Perseus-Soros Biopharmaceutical Fund, Aisling Capital.
CeNeRx BioPharma has raised $32.9M across 3 funding rounds. Most recently, it raised $4.8M Other Equity in December 2011.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 9, 2011 | $4.8M Other Equity | L Capital Partners, Omega Funds, Pappas Ventures, Perseus-Soros Biopharmaceutical Fund | |
| Aug 13, 2010 | $13.0M Series C | L Capital Partners, Pappas Ventures, Perseus-Soros Biopharmaceutical Fund | |
| Oct 17, 2008 | $15.0M Other Equity | Aisling Capital, L Capital Partners, Pappas Ventures |